64 results
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... for First Time Pulmonary ... #PE #Pulmonary # ... #Algorithm #management ... #hematology #VTE
Bronchiectasis: diagnosis and management 

Causes of localized -> diffuse bronchiectasis
Foreign body, Bronchial stenosis (tumor, .. ),
diagnosis and management ... Causes of localized ... Mycobacteria, Whooping ... Differential #workup #algorithm ... #pulmonary
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... Task Force on Clinical ... #CHF #guideline ... ACCAHA2017 #cardiology #treatment ... #algorithm #sCHF
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... disease or CHF) ... disease or CHF) ... #management #cardiology ... #algorithm
Algorithm for the Evaluation and Management of Sickle Cell Crises
Clinical Manifestations and Management

#Diagnosis #Management #Hematology #SickleCell
Algorithm for the ... of Sickle Cell Crises ... Clinical Manifestations ... #Hematology #SickleCell ... Manifestations #Workup #Algorithm
STAGES of CHF (A, B, C, D), however, describe the severity of structural abnormalities that impair
sometimes advanced treatment ... flare ups that cause ... Treatments may include ... #Management #Cardiology ... Stages #ACCAHA #Algorithm
Hypereosinophilia and Hypereosinophilic Syndrome

 • Secondary Hypereosinophilic Syndrome
 • Clinically Relevant HES Variants
 • When to
Hypereosinophilic Syndrome • Clinically ... Diagnosis and Treatment ... Syndrome #HES #Hematology ... eosinophils #diagnosis #management ... #algorithm
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Decompensated CHF ... • Obstructive: Pulmonary ... Dehydration Shock Treatment ... #criticalcare #algorithm ... #treatment #management
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... without other cause ... : 33% • Treatment ... : Age>60, CKD, CHF ... , and CXR with pulmonary
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... thrombosis; PE = pulmonary ... Anticoagulation #Management ... #Hematology #Oncology